Market Size (2015)
2015
—
Healthcare
Concussions Market
By Segment, By Region, And Segment Forecasts, 2015 – 2023
Vertical: HealthcareBase Year: 201712 Sections
Executive Summary
Concussions Market — Snapshot
Projected (2023)
2023
—
CAGR (2015–2023)
N/A
Key Players
108+
Head injuries that are severe enough to affect brain functions are termed as traumatic brain injuries (TBI). A concussion is a form of mild traumatic brain injuries. In the majority of the people, recovery from a mild concussion is quick. However, if the person suffers a severe concussion, proper treatment is required. Currently, there is no targeted treatment available for concussions. In recent years, the prevalence rate of concussions has increased significantly. According to the Centers for Disease Control and Prevention, nearly 1.6 to 3.8 million sports and recreation-related concussions occur yearly in the US. Besides that, growing product development for the management of concussions by several companies is anticipated to fuel market growth. Additionally, the growing geriatric population globally is expected to support the growth of the market in the coming years.
The global concussions market was valued at USD 868.59 million in 2017, and the market is estimated to grow at USD 1060.36 million by 2023. In 2017, the Americas accounted for the largest market share of 43.7% with a market value of USD 379.43 million, followed by Europe with a market value of USD 249.37 million in 2017.
The global concussions market has been segmented based on diagnosis and treatment, end user, and region.
Based on diagnosis and treatment, the diagnosis segment accounted for the largest market share of 94.2% in 2017, with a market value of USD 818.09 million, which is projected to register a CAGR of 3.18% during the forecast period.
On the basis of end user, the market has been segmented into hospitals and clinics, diagnostic centers, payers, and others. The hospitals and clinics segment accounted for the largest market share of 58.2% in 2017, with a market value of USD 505.78 million, which is projected to register a CAGR of 2.97% during the assessment period.
1.1 Market Attractiveness Analysis
Key Insight
Concussions Market is a key focus area for market intelligence and strategic research.
Market Performance Trend
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Scope & Coverage
What this report covers
- Geographic Coverage: This analysis covers 4 regions: Middle East and Africa, Americas, Asia Pacific, Europe.
- Market Segmentation: The market is analyzed across key segments with forecasts from 2015 to 2023.
- Competitive Landscape: 108 leading companies are profiled, covering market positioning, strategies, and recent developments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Overview
Concussions Market — Growth Trajectory
A concussion is a mild traumatic brain injury that disrupts the normal function of the brain temporarily. Concussions are generally caused by a blow or jolt to the head. However, it can occur from a hit to the body that produces a reflex force to the head. Concussions are majorly seen in falls, sports, and car crashes. The global market for concussions is expected to propel owing to factors such as increasing prevalence of mild traumatic brain injuries, ongoing product development for concussion management, and growing elderly population globally. However, the shortage of trained professionals and a stringent regulatory framework are anticipated to hamper the growth of the global concussions market.
Market Share by Application
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Dimensions
How this market is segmented
- Diagnosis & Treatment Diagnosis & Treatment is broken down into: Diagnosis, Treatment.
- End User End User is broken down into: Hospitals and Clinics, Diagnostic Centers, Payers.
Geographic Analysis
Regional market breakdown
- Middle East and Africa Middle East and Africa is one of the key regions covered in this market analysis.
- Americas Americas is one of the key regions covered in this market analysis.
- Asia Pacific Asia Pacific is one of the key regions covered in this market analysis.
- Europe Europe is one of the key regions covered in this market analysis.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansResearch Methodology
Concussions Market — How We Researched This Market
3.1 Research Process
Market Research Future analysis is based on interviews with industry experts who offer insight into the market structure, market segmentation, technology assessment, competitive landscape (CL), market penetration, as well as the emerging trends. Besides primary interviews (~80%) and secondary research (~20%), their analysis is based on years of professional expertise in their respective industries. Our analysts also predict where the market will be headed in the next five to 10 years, by analyzing historical trends and the current market position. Furthermore, the varying trends in segments and categories in each region are studied and estimated based on primary and secondary research.
3.2 Primary Research
Extensive primary research was conducted to gain a deeper insight into the market and industry performance. For this particular report, we have conducted primary surveys (interviews) with the key level executives (VPs, CEOs, marketing directors, and business development managers, among others) of the major players active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed in the next five to 10 years.
3.3 Secondary Research
Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the global concussions market. It was also used to obtain key information about major players, market classification and segmentation according to industry trends, and developments related to the market and technology. For this study, analysts have gathered information from various credible sources such as the Brain Injury Association of America, American Association of Neurological Surgeons, European Brain Council, Center for Disease Control and Prevention, United States Food and Drug Administration, Center on Brain Injury Research and Training, National Institute of Neurological Disorders and Stroke, European Association for Injury Prevention and Safety Promotion, National Concussion Surveillance System, Expert Interviews, Annual Reports, SEC filings, Research Journals, White Papers, Corporate Presentations, Company Websites, MRFR Analysis, and paid databases.
3.4 Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of the overall global concussions market. The key players in the market were identified through secondary research, and their market contributions in different applications across the globe were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Market Research Future added before being presented in this report. The following figure shows an illustrative representation of the overall market size estimation process employed for this study.
Base Year
2017
Historical Period
2015 – 2017
Forecast Period
2017 – 2023
Primary Interviews
150+
Research Process
Historical data (2015–2017) and forecast period (2017–2023)
1
Problem Definition
- Market scoping
- Objective setting
- Framework design
2
Secondary Research
- Literature review
- Data mining
- Trend analysis
3
Primary Research
- Expert interviews
- Field visits
- Surveys
4
Data Analysis
- Quantitative modeling
- Statistical testing
- Validation
5
Insights & Reporting
- Synthesis
- Recommendations
- Visualization
Research Depth
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Competitive Landscape & Porter's Five Forces
Concussions Market — Competitive Analysis
5.1.1 Bargaining Power of Suppliers
In the global concussions industry, suppliers are raw materials’ manufacturers such as chemical suppliers for pharmaceuticals and intermediate Original Equipment Manufacturers (OEMs) for medical devices like magnetic resonance imaging (MRI). There is a huge number of suppliers in the global concussions market, thus, leading to a moderate amount of bargaining power in the market. The switching cost of these suppliers is moderate as the suppliers tend to enter long-term associations with the manufacturers. Thus, the bargaining power of suppliers is moderate.
5.1.2 Bargaining Power of Buyers
The bargaining power of buyers is low to moderate in the global concussions market. The market has a moderate number of buyers which includes providers such as hospitals and clinics, research centers, educational institutions, and payers. The buyers in the global concussions market hold only a certain degree of power over the market players because of the moderate concentration of the buyers.
5.1.3 Threat of New Entrants
The threat of new entrants in the global concussions market is moderate. The global concussions market is growing at a steady pace due to the increasing number of sports injuries worldwide, rising R&D funding for the development of new diagnostic devices. Companies involved in the mergers and acquisitions and rapid product launches are generating a huge amount of profit and influencing the potential companies to enter into this market. The specialist knowledge or expertise related to product development and the huge capital required for the development of diagnostic products acts as an entry barrier for the new players. Further, several small and medium-size companies are creating their space and trying to capture the market share which mostly untouched by major players.
5.1.4 Threat of Substitutes
The threat of substitutes in the global concussions market is medium. The innovation and launch of new imaging diagnostics systems for the diagnosis of brain injuries are increasing the threat of substitution for existing products. The customers tend to select the product according to their need and which provide the best results. The other factors that increase the threat of substitutes are low brand loyalty in the case of pharmaceutical drugs. So, the companies are focusing on developing high-quality, and cost-effective products as per the market need to decrease the threat of substitute.
5.1.5 Intensity of Rivalry
The intensity of rivalry in the global concussions market is moderate to high. The rising demand for imaging techniques and diagnostic products by the end user such as hospitals and research academies are contributing to the increase in rivalry among the companies to capture a large market. Also, the increase in similar types of product offered by different companies increases the competition among the companies. The rise in the number of players decreases the profit share for each company and results to increase the intensity of competition in the respective market. Moreover, companies involved in manufacturing drugs such as analgesics and anticonvulsant are facing intense rivalry owing to the presence of many small and medium scale companies.
Empower your Business
with InsightsSave over 20% on
with Insights
Save over 20% on
Annual Subscription
See plans for professionals or small and medium businesses.
Analytics
Concussions Market — Key Findings
Analytical insights on Concussions Market covering market dynamics, competitive landscape, and strategic outlook.
Key Analytical Findings
Concussions Market represents a significant market opportunity with multiple growth drivers across regions and segments.
Market Drivers
A concussion is a brain injury that temporarily affects the functioning of the brain. Concussions may induce problems such as headaches, memory problems, concentration, coordination, and balance.According to an article by Johns Hopkins Medicine, a blow or a jolt to the head can lead to a concussion or traumatic brain injury (TBI). Factors such as increased incidence of mild traumatic brain injuries, ongoing product development and approval, and rising geriatric population are expected to fuel the growth of the global concussions market. Despite the drivers, the shortage of skilled physicians and the stringent regulatory framework are likely to affect market growth over the forecast period negatively.
Market Opportunities
Recently, the increased news reports about the long-term brain damage occurring from concussions especially due to sports such as football and soccer have highlighted the dangers associated with concussions. The rise in awareness about concussions has encouraged lawmakers to create legislation to protect children who may sustain a concussion while playing contact sports. For instance,all 50 states in the US and Washington D.C., have enacted various laws for concussions. For instance, the Zachery Lystedt Law was the first state concussion law to be passed in the US, named after a 13-year-old football athlete who was disabled by a serious concussion in 2006. Likewise, Jenna's Law was enacted in 2013 and became effective on January 1, 2014. Senate Bill 721 or Jenna’s Law requires non-youth sports leagues to educate parents, referees, coaches, and children over 12 to recognize the symptoms of concussions.
Moreover, the long-term impact of concussions on professional athletes has led researchers and sports medicine professionals to look more closely at concussions suffered by student-athletes. In addition to this, schools in developed countries have started imparting concussion education. For instance, in Arizona, the awareness about concussions is growing. According to the survey carried out in 2016, about 75% of student-athletes in Arizona received concussion education. Furthermore, in Australia, in recent years there had been an elevated public awareness of sport-related concussions and increased focus on the importance of diagnosing and managing the condition promptly, safely, and appropriately.
Thus, the rising awareness about concussions in developed and developing regions are likely to provide favorable backgrounds for the market to grow.
Market Restraints
High level of regulatory compliance standards set by regulatory agencies to minimize the risk to patients has made the new product approval process difficult for manufacturers. The US Food Drug and Administration (FDA) is a globally renowned regulatory body engaged in monitoring and approving drugs and medical devices. The manufacturers of medical devices are required to follow the rules stated by the US FDA and have to comply with the policies. The life of patients relies on these devices and hence they should provide accurate and precise results. Although regulatory compliance standards help the end-user to get quality products, these strict policies create a problem for market players to introduce advanced products in the market, which can eventually hamper the growth of the market.
Strategic Outlook and Future Directions
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Companies
Key companies profiled in Concussions Market
Profiles of 108 companies operating in the Concussions Market market, including revenue, employee count, and market positioning where available.
Showing 108 of 108 companies
Zydus Cadi
Zydus Cadila
Healthcare
Company Headquarters: Ahmedabad, India Founded: 1952 Workforce: 23,000+ Company Working: Zydus Cadila is one of the leading Indian pharmaceutical companies. It has in-depth domain expertise in the field of healthcare. It also has strong capabilities across the range of the pharmaceutical value chain. The company provides comprehensive and complete healthcare solutions ranging from formulations to APIs and animal healthcare products to wellness products. Its presence spreads across four continents. The company ranks fourth in the Indian pharmaceutical industry with manufacturing and research facilities spread across five states of Gujarat, Maharashtra, Goa, Himachal Pradesh, and Sikkim. Globally, Zydus Cadila has a strong presence in regulated markets of the US, Europe (France and Spain), and the high-profile markets of Latin America and South Africa. It also has a strong presence in 25 other emerging markets worldwide.
Revenue$1.4B
Employees23,000
Market CapN/A
Founded1951
Ahmedabad, India
Integra Li
Integra LifeSciences Corporation
Healthcare
Company Headquarters: New Jersey, US Founded: 1989 Workforce: ~4,500 Company Working: Integra LifeSciences Holdings Corporation (Integra) is a world leader in medical technology. It offers innovative solutions for orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive & general surgery. Integra offers a broad portfolio of brands that include AmnioExcel, Bactiseal, Cadence, Certas, Codman, CUSA, DuraGen, DuraSeal, ICP Express, Integra, MediHoney, MicroFrance, PriMatrix, Salto Talaris, SurgiMend, TCC-EZ, Titan, and VersaTru. It sells its products through two business segments, namely, Codman specialty surgical and orthopedics and tissue technologies. It recently acquired one of the leading players of the global amniotic membrane market, Derma Sciences Inc. (US), a tissue regeneration company. Integra provides its innovative healthcare solutions in over 130 countries through more than 50 offices and worldwide distribution networks.
Revenue$1.0B
Employees4,500
Market CapN/A
Founded1988
New Jersey, US
Teva Pharm
Teva Pharmaceutical Industries Ltd
Healthcare
Company Headquarters: Petah Tikva, Israel Founded: 1901 Workforce: 43,000+ Company Working: Teva Pharmaceutical Industries Ltd (Teva) is one of the leaders in pharmaceutical industries engaged in developing and providing services in generic medicines. The company has more than 1,800 molecules which are used to create an extensive variety of generic products in almost every therapeutic area. It is specialized in generic medicines, the central nervous system (CNS), brand and specialty medicines, oncology, active pharmaceutical ingredients, respiratory, women's health, and biologics fields. It has more than 35,000 unique products, which is more than any other pharmaceutical company. Teva produced 120 billion tablets and capsules in 2017. Geographically, it operates in regions, namely, North America, Latin America, Europe, Japan, and South Korea. The company operates in more than 60 countries worldwide. It has 26 FDA approved plants, and 31 European Medicines Agency (EMA) approved plants worldwide.
Revenue$16.9B
Employees43,000
Market CapN/A
Founded1900
Petah Tikva, Israel
SANOFI
SANOFI
Healthcare
Sanofi is a UK-based global life sciences company which was incorporated in the year 2004. Sanofi is headquartered in Paris having the employee strength of more than 110,000 spread in more than 100 countries and have industrial sites in more than 40 countries. The company is committed to improve the access to healthcare and support the people to whom it serves throughout the continuum of care. Further, the company has its offerings into healthcare solutions, human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions, and consumer healthcare. Sanofi CEPiA is a subsidiary business unit of Sanofi that produces articaine hydrochloride in API form. It is a market leader in producing articaine hydrochloride. The company manufactures articaine hydrochloride in its high capacity FDA approved workshop. Sanofi’s Ankleshwar production plant has an export sales of Rs. 54,900 lakhs that is around 27% of their total sales in India in 2015 . Their healthcare solutions are available in more than 170 countries across the world and now Sanofi is focussing on increasing its presence in emerging countries. Their industrial network, know-how and employees deliver a wide range of health solutions to millions of individuals with high quality and safety. Some of the top competitors of Sanofi are Pfizer Inc., Merck & Co., Inc. GlaxoSmithKline Plc., Septodont, Dentsply Sirona, and Pierrel S.p.A., among others.
Revenue$40.5B
EmployeesN/A
Market CapN/A
FoundedN/A
United States, North America
Novartis A
Novartis AG
Healthcare
Company Headquarters: Basel, Switzerland Founded: 1996 Workforce: ~126,000 Company Working: Novartis AG (Novartis) was established in 1996 through a merger of Ciba-Geigy and Sandoz. Novartis and its preceding companies have been known to develop innovative products which can be traced back to over 250 years. The company focuses on the development and marketing of products that contribute to human progress through advances in science and health. It provides products that find applications in cancer, cardio-metabolic, immunology and dermatology, ophthalmology, neuroscience, and respiratory disease areas. Its Sandoz segment offers active ingredients and finished dosage forms of pharmaceuticals in cardiovascular, dermatology, central nervous system (CNS), gastrointestinal and hormonal therapy, metabolism, oncology, ophthalmic, pain, and respiratory areas, among others. It also provides active pharmaceutical ingredients (API) and intermediates primarily antibiotics, protein- or other biotechnology-based products including biosimilars, and biotechnology manufacturing services.
Revenue$48.7B
Employees126,000
Market CapN/A
Founded1995
Basel, Switzerland
Sun Pharma
Sun Pharmaceutical Industries Ltd
Healthcare
Company Headquarters: Mumbai, India Founded: 1983 Workforce: ~30,000 Company Working: Sun Pharmaceutical Industries Ltd (Sun Pharma) is one of India’s top pharmaceutical companies. It is the world’s fourth-largest generic pharmaceutical company. The company has vertically integrated businesses, high economies of scale, and a highly-skilled team. Sun Pharma delivers high-quality and reasonable medicines trusted by customers in over 150 countries globally, such as the US, Canada, Brazil, Germany, France, Russia, Japan, and South Africa. It also has a specialty products portfolio which contains ten specialty products, out of which five are in the market, three are likely to be commercialized soon, and two are awaiting USFDA approvals. It has its products in various leading therapeutic areas such as diabetes, oncology, pain, autoimmune diseases, respiratory diseases, antibiotics and vaccines, cardiovascular, HIV, mental health, and antivirals. Sun Pharma sells its duloxetine and atorvastatin products under the brand name AZTOR.
Revenue$4.1B
Employees30,000
Market CapN/A
Founded1982
Mumbai, India
Page 1 of 18
…
Go to page
Powering the world's best teams.
From next-gen startups to established enterprises.
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence
Noah Malgeri
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Noah Malgeri
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Concussions Market
Starting from
$4,950